Description of a Retrospective Cohort of Epithelial Ovarian Cancer Patients with Brain Metastases: Evaluation of the Role of PARP Inhibitors in this Setting.

Zena AlizziPatricia RoxburghDouglas CartwrightAlistair McLarenSarah ParkRachel JonesSemini GreeningEmma HudsonClare GreenSimon GraySaira KhaliqueEmmanouil KarterisMarcia Hall

Published in: Journal of clinical medicine (2023)

As with abdominal relapse, maintenance treatment with PARP inhibitors also has a valuable role in managing BMs in EOC patients.

Keyphrases

brain metastases
end stage renal disease
small cell lung cancer
dna damage
newly diagnosed
dna repair
ejection fraction
chronic kidney disease
prognostic factors
peritoneal dialysis
patient reported
replacement therapy